TORONTO, May 28 /PRNewswire-FirstCall/ -- DRAXIS Health Inc. ("DRAXIS") (TSX: DAX) (NASDAQ:DRAX) announced today the completion of the statutory arrangement under which all of DRAXIS' common...
Court approves acquisition of DRAXIS by Jubilant TORONTO, May 27 /PRNewswire-FirstCall/ -- DRAXIS Health Inc. ("DRAXIS") (TSX: DAX) (NASDAQ:DRAX) announced today that it has obtained a Final...
TORONTO, May 23 /PRNewswire-FirstCall/ -- DRAXIS Health Inc. ("DRAXIS" or the "Company") (TSX: DAX) (NASDAQ:DRAX) announced today that the plan of arrangement under the Canada Business...
MONTREAL, May 9 /PRNewswire-FirstCall/ -- DRAXIS Health Inc. (TSX: DAX) (NASDAQ:DRAX) reported first quarter financial results for the three months ended March 31, 2008. Revenues and earnings...
MONTREAL, May 6 /PRNewswire-FirstCall/ -- DRAXIS Health Inc. (TSX: DAX) (NASDAQ:DRAX) will report financial and operating results for its First Quarter 2008 on Friday May 9, 2008. Annual and...
Annual and special meeting of shareholders set for May 23, 2008 TORONTO, April 24 /PRNewswire-FirstCall/ -- DRAXIS Health Inc. ("DRAXIS") (TSX: DAX) (NASDAQ:DRAX) announced today that it has...
All-cash transaction at US$6.00 per share NOIDA, India and TORONTO, April 4 /PRNewswire-FirstCall/ -- Jubilant Organosys Ltd. ("Jubilant") (BSE:530019BSE:NSE:BSE:JUBILANT) and DRAXIS Health Inc...
MONTREAL, March 17 /PRNewswire-FirstCall/ -- DRAXIS Health Inc. (the "Company") (TSX: DAX) (NASDAQ:DRAX), in response to a request by securities regulators with respect to increased trading in...
MONTREAL, Feb. 7 /PRNewswire-FirstCall/ -- DRAXIS Health Inc. (TSX: DAX); (NASDAQ:DRAX) reported financial results for the fourth quarter and the year ended December 31, 2007. Results for the...
MONTREAL, Jan. 31 /PRNewswire-FirstCall/ -- DRAXIS Health Inc. (TSX: DAX) (NASDAQ:DRAX) will report financial and operating results for its Fourth Quarter and Year End 2007 on Thursday February...
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관